Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Nature|February 22, 2023
Atomic Bose-Einstein condensate in twisted-bilayer optical latticesZengming Meng, Liangwei Wang, Wei Han, et al.
Lupus Science & Medicine|December 28, 2018
Anifrolumab effects on rash and arthritis: impact of the type I interferon gene signature in the phase IIb MUSE study in patients with systemic lupus erythematosusJoan T Merrill, Richard Furie, Victoria P Werth, et al.
Scientific Reports|April 5, 2020
Observation of sub-wavelength phase structure of matter wave with two-dimensional optical lattice by Kapitza-Dirac diffractionKai Wen, Zengming Meng, Pengjun Wang, et al.
The New England Journal of Medicine|September 7, 2017
Tezepelumab in Adults with Uncontrolled AsthmaJonathan Corren, Jane R Parnes, Liangwei Wang, et al.
Modern Rheumatology|February 23, 2019
Safety and tolerability of anifrolumab, a monoclonal antibody targeting type I interferon receptor, in Japanese patients with systemic lupus erythematosus: A multicenter, phase 2, open-label studyYoshiya Tanaka, Tsutomu Takeuchi, Masato Okada, et al.
Annals of the Rheumatic Diseases|March 25, 2016
Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled studyMunther Khamashta, Joan T Merrill, Victoria P Werth, et al.
Modern Rheumatology|February 23, 2019
Safety and tolerability of sifalimumab, an anti-interferon-α monoclonal antibody, in Japanese patients with systemic lupus erythematosus: A multicenter, phase 2, open-label studyTsutomu Takeuchi, Yoshiya Tanaka, Ryutaro Matsumura, et al.
Lupus Science & Medicine|December 13, 2018
Type I interferon receptor blockade with anifrolumab corrects innate and adaptive immune perturbations of SLEKerry A Casey, Xiang Guo, Michael A Smith, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 29, 2017
Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus ErythematosusRichard Furie, Munther Khamashta, Joan T Merrill, et al.
Arthritis and Rheumatism|February 13, 2013
Sifalimumab, a human anti-interferon-α monoclonal antibody, in systemic lupus erythematosus: a phase I randomized, controlled, dose-escalation studyMichelle Petri, Daniel J Wallace, Alberto Spindler, et al.
Pageof 3